830 related articles for article (PubMed ID: 25500798)
41. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
42. DJ-1 protects dopaminergic neurons against rotenone-induced apoptosis by enhancing ERK-dependent mitophagy.
Gao H; Yang W; Qi Z; Lu L; Duan C; Zhao C; Yang H
J Mol Biol; 2012 Oct; 423(2):232-48. PubMed ID: 22898350
[TBL] [Abstract][Full Text] [Related]
43. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.
Zhou W; Freed CR
J Biol Chem; 2005 Dec; 280(52):43150-8. PubMed ID: 16227205
[TBL] [Abstract][Full Text] [Related]
44. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
Hennis MR; Marvin MA; Taylor CM; Goldberg MS
Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
[TBL] [Abstract][Full Text] [Related]
45. Combining fibril-induced alpha-synuclein aggregation and 6-hydroxydopamine in a mouse model of Parkinson's disease and the effect of cerebral dopamine neurotrophic factor on the induced neurodegeneration.
Singh A; Panhelainen A; Reunanen S; Luk KC; Voutilainen MH
Eur J Neurosci; 2024 Jan; 59(1):132-153. PubMed ID: 38072889
[TBL] [Abstract][Full Text] [Related]
46. DJ-1 deficiency perturbs microtubule dynamics and impairs striatal neurite outgrowth.
Sheng C; Heng X; Zhang G; Xiong R; Li H; Zhang S; Chen S
Neurobiol Aging; 2013 Feb; 34(2):489-98. PubMed ID: 22609282
[TBL] [Abstract][Full Text] [Related]
47. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
[TBL] [Abstract][Full Text] [Related]
48. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
[TBL] [Abstract][Full Text] [Related]
49. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
50. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
[TBL] [Abstract][Full Text] [Related]
51. Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP
Kawahata I; Bousset L; Melki R; Fukunaga K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661838
[TBL] [Abstract][Full Text] [Related]
52. A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.
Das B; Rajagopalan S; Joshi GS; Xu L; Luo D; Andersen JK; Todi SV; Dutta AK
Neuropharmacology; 2017 Sep; 123():88-99. PubMed ID: 28533164
[TBL] [Abstract][Full Text] [Related]
53. Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models.
Park HJ; Zhao TT; Lee KS; Lee SH; Shin KS; Park KH; Choi HS; Lee MK
Neurochem Int; 2015; 83-84():19-27. PubMed ID: 25747493
[TBL] [Abstract][Full Text] [Related]
54. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
[TBL] [Abstract][Full Text] [Related]
55. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.
Liu F; Nguyen JL; Hulleman JD; Li L; Rochet JC
J Neurochem; 2008 Jun; 105(6):2435-53. PubMed ID: 18331584
[TBL] [Abstract][Full Text] [Related]
57. Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.
Zhao X; Zhai S; An MS; Wang YH; Yang YF; Ge HQ; Liu JH; Pu XP
PLoS One; 2013; 8(10):e78220. PubMed ID: 24205164
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
Decressac M; Mattsson B; Björklund A
Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
[TBL] [Abstract][Full Text] [Related]
59. Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.
Lev N; Barhum Y; Ben-Zur T; Melamed E; Steiner I; Offen D
J Mol Neurosci; 2013 Jul; 50(3):542-50. PubMed ID: 23536331
[TBL] [Abstract][Full Text] [Related]
60. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z
Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
